By physician referral or invitation only

ZX008 for Subjects with CDKL5 Deficiency Disorder

The purpose of this study is to test the efficacy of ZX008 for kids and adults with CDD. We will measure this based on a decrease in motor seizures and using the Clinical Global Impression- Improvement rating scale.

Age & Gender

2 years ~ 35 years
Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

United States (Nationwide)

Additional Study Information

Principal Investigator

Yael Shiloh-Malawsky
Neurology

Study Type

Clinical or Medical
Interventional

Study Topics

Genetics and Genetic Disorders

IRB Number

21-2303

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.